Selective serotonin-reuptake inhibitors (SSRIs) are first-line treatments for major depressive disorders and post-traumatic stress disorder (PTSD), but SSRIs and related therapeutics take weeks to…
In connection to World Patient Safety Day 2023, Dr Stefanie Lip and Dr Linsay McCallum explore a recent project to enhance awareness of medicines reconciliation and emphasise the importance of…
The Society is delighted to announce its 2023 recipients of the Sir Colin Dollery Clinical Pharmacology Training Award. The award provides a bursary to intercalating medical students studying…
Last year, we launched our Strategic Plan 2022-24. As we approach the third and final year of this plan, we have been assessing our progress and ensuring we are prepared to reach our core…
The British Pharmacological Society (BPS) is now leading the UK Pharmacogenetics & Stratified Medicine Network (UKPGx).The UKPGx Network was set up in 2010 to develop research collaborations…
We are delighted to announce the winners of this year’s Student Contribution to Pharmacology Prize. The prize enables universities in the UK and Ireland, who are offering medicine or…
A team from Bristol Myers Squibb are the winners of the 2024 Sir James Black Drug Discovery of the Year Award, with their drug mavacamten for obstructive hypertrophic cardiomyopathy.The…
The British Pharmacological Society (BPS) is sad to report the death of Professor David Brown. Professor Brown joined the BPS in 1965 and was elected to Honorary Fellowship in 2005. Professor Brown…
The UK Prescribing Safety Assessment (PSA) is a ground-breaking medical exam with strong stakeholder support and is associated with increased confidence in prescribing and decreased reporting of…
The Geoffrey Burnstock Prize was launched earlier this year to recognise the achievements of established researchers through their publications.We are delighted to anounce that the recipient of…
